The Pact
We the undersigned leaders in the biotechnology industry and life science investors in Europe and in the US recognize that at this pivotal moment in the history of our industry, we are at the dawn of a golden age of medicine. We will soon have the ability to treat and cure diseases which have been untreatable and incurable.
Our industry is unique. We save, extend and enhance lives by alleviating the burden of disease. Our mission is to change the course of each individual’s life for the better. To achieve this, we acknowledge that we have a moral obligation to develop the best medicines and strive to ensure that every person who may benefit has access to them. And we need to ensure that we act with the highest integrity and corporate responsibility- always prioritizing the interests of patients.
So, to fulfill our obligations to patients, physicians, public authorities across Europe and to renew trust and confidence in how we deliver on our mission, each of us affirms a New European Biotech Social Pact, informed by these Core Principles and Actions:
Signatories
The Biotech Social Pact is a community of industry leaders united by an ambition to deliver breakthrough medical innovations that transform patients’ lives. The community continues to evolve and grow as new leaders join the initiative.
Please click the list to see the full text of the Biotech Social Pact and its signatories.